IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myelomaJennifer Sun(Washington University in St. Louis), Abdel Kareem Azab(Southwestern Medical Center)LeukemiaAugust 30, 202410.1038/s41375-024-02391-8Cited by 35SaveCiteExport RISWatch citationsRelated PapersThe role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy|Hypoxia|2015|2.1kTumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma|Nature Communications|2020|75